The meaning of a high plasma free haemoglobin: Retrospective review of the prevalence of haemolysis and circuit thrombosis in an adult ECMO centre over 5 years

Perfusion (United Kingdom)

Volumn 31, Issue 3, 2016, Pages 223-231

  Pan, Kevin C ^a   McKenzie, D P ^b   Pellegrino, V ^a   Murphy, D ^a   Butt, W ^c,d,e  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

adult; critical care; extracorporeal membrane oxygenation; haemolysis; thrombosis

Indexed keywords

FIBRINOGEN; HEMOGLOBIN;

ADULT; ARTICLE; BLOOD CLOT LYSIS; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL OXYGENATION; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; FLOW; HEMOFILTRATION; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; OXYGENATOR THROMBOSIS; PARTIAL THROMBOPLASTIN TIME; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUMP HEAD THROMBOSIS; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOSIS; TREATMENT DURATION; ADVERSE EFFECTS; BLOOD; HOSPITAL MORTALITY; METABOLISM; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY;

ADULT; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HEMOGLOBINS; HEMOLYSIS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 84960800040     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659115595282     Document Type: Article

References (19)

1. Steinhorn RH, Isham-Schopf B, Smith C, et al. Hemolysis during long-term extracorporeal membrane oxygenation. J Pediatr 1989; 115: 625-630.
2. Horton AM, Butt W,. Pump-induced haemolysis: is the constrained vortex pump better or worse than the roller pump? Perfusion 1992; 7: 103-108.
3. Toomasian JM, Bartlett RH,. Hemolysis and ECMO pumps in the 21st century. Perfusion 2011; 26: 5-6.
4. Schaer D, Buehler P, Alayash AI, et al. Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood 2013; 121: 1276-1284.
5. Gbadegesin R, Zhao S, Charpie J, et al. Significance of hemolysis on extracorporeal life support after cardiac surgery in children. Pediatr Nephrol 2009; 24: 589-595.
6. Lou S, MacLaren G, Best D, et al. Hemolysis in pediatric patients receiving centrifugal-pump extracorporeal membrane oxygenation: prevalence, risk factors, and outcomes. Crit Care Med 2014; 42: 1213-1220.
7. Lequier L, Horton S, McMullan D, et al. Extracorporeal membrane oxygenation circuitry. Pediatr Crit Care Med 2013; 14: S7-S12.
8. Aubron C, Cheng AC, Pilcher D, et al. Factors associated with outcomes of patients on extracorporeal membrane oxygenation support: a 5-year cohort study. Crit Care 2013; 17: R73.
9. Maclaren G, Butt W,. Extracorporeal membrane oxygenation and sepsis. Crit Care Resusc 2007; 9: 76-80.
10. MacLaren G, Butt W, Best D, et al. Central extracorporeal membrane oxygenation for refractory pediatric septic shock. Pediatr Crit Care Med 2011; 12: 133-136.
11. Lippi G, Franchini M,. Coagulation testing in pediatric patients: the young are not just miniature adults. Semin Thrombo Hemost 2007; 33: 816-820.
12. Dellinger RP,. Inflammation and coagulation: implications for the septic patient. Clin Infect Dis 2003; 36: 1259-1265.
13. Liveris A, Bello RA, Friedmann P, et al. Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation. Pediatr Crit Care Med 2014; 15: e72-e79.
14. Irby K, Swearingen C, Byrnes J, et al. Unfractionated heparin activity measured by anti-factor Xa levels is associated with the need for extracorporeal membrane oxygenation circuit/membrane oxygenator change: a retrospective pediatric study. Pediatr Crit Care Med 2014; 15: e175-e182.
15. Rother RP, Bell L, Hillmen P, et al. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 1653-1662.
16. Peek G, Firmin R,. The inflammatory and coagulative response to prolonged extracorporeal membrane oxygenation. ASAIO J 1999; 45: 250-263.
17. Tayama E, Hayashida N, Akasu K, et al. Biocompatibility of heparin-coated extracorporeal bypass circuits: new heparin bonded bioline system. Artif Organs 2000; 24: 618-623.
18. Cheung PY, Sawicki G, Salas E, et al. The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med 2000; 28: 2584-2590.
19. Kestin BAS, Valeri CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993; 82: 107-117.